Momelotinib: second-line treatment for myelofibrosis with anemia

被引：0
|
作者：
Lauren, Barette
机构：
来源：
HEMATOLOGIE | 2023年 / 29卷 / 05期
关键词：
RUXOLITINIB;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：267 / 269
页数：3
相关论文
共 50 条
  • [1] Momelotinib for the treatment of myelofibrosis with anemia
    Tremblay, Douglas
    Mesa, Ruben
    [J]. FUTURE ONCOLOGY, 2022, 18 (20) : 2559 - 2571
  • [2] Momelotinib: Treatment option for patients with myelofibrosis and anemia
    Schoellmann, Claudia
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (03) : 104 - 105
  • [3] Momelotinib: an emerging treatment for myelofibrosis patients with anemia
    Chifotides, Helen T.
    Bose, Prithviraj
    Verstovsek, Srdan
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [4] Momelotinib: an emerging treatment for myelofibrosis patients with anemia
    Helen T. Chifotides
    Prithviraj Bose
    Srdan Verstovsek
    [J]. Journal of Hematology & Oncology, 15
  • [5] Momelotinib: Treatment Option for Patients with Myelofibrosis and Anemia
    Schoellmann, Claudia
    [J]. ACTA HAEMATOLOGICA, 2024, 147 (02) : 254 - 255
  • [6] Momelotinib for the treatment of myelofibrosis
    Xu, Li
    Feng, Juan
    Gao, Guangxun
    Tang, Hailong
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (16) : 1943 - 1951
  • [7] Momelotinib for the treatment of myelofibrosis
    Bose, Prithviraj
    [J]. BLOOD, 2024, 144 (07) : 708 - 713
  • [8] Myelofibrosis and Anemia: Momelotinib receives Approval in the EU
    Habel, Christoph
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (04) : 163 - 163
  • [9] Myelofibrosis and Anemia: Momelotinib receives Approval in the EU
    Habel, Christoph
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024, 51 (02) : 128 - 128
  • [10] Interferon Alfa as a First- and Second-Line Treatment Option for Primary Myelofibrosis
    Sghibneva-Bobeico, Nina
    Musteata, Vasile
    Robu, Maria
    Covalschi, Elena
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S391 - S391
12345